Gabriela R. Rossi

Gabriela R. Rossi has a diverse work experience in the field of immunology and cancer research. Gabriela R. currently holds the position of EVP Immunology at SyncromuneTM since December 2020. In addition, they are the Chief Executive Officer of the Gaby Rossi Foundation, a position they assumed in February 2021.

Prior to these roles, Rossi served as the Chief Research Officer at SIWA Therapeutics from October 2020, where their responsibilities included leading research initiatives. Gabriela R. also has extensive experience at NewLink Genetics, where they held various positions. As the Vice President Cancer Biology and Immunology from January 2013 to October 2019, Rossi developed biomarker programs, designed and implemented immunological monitoring of clinical trials, and developed state-of-the-art biological therapies, including gene-therapy products.

At NewLink Genetics, they also served as the Senior Director Tumor Immunology from January 2007 to December 2013, where they focused on clinical trials development, mechanism of action studies, and development of new vaccine candidates. Prior to this, they worked as a Senior Scientist from September 2003 to December 2007.

Before joining NewLink Genetics, Rossi worked at John Stoddard Cancer Info as a Research and Development Scientist from January 2002 to September 2003, where they specialized in tumor immunology and the development of cancer vaccines. Gabriela R. also gained research experience as a Research and Development Scientist at the National Cancer Institute (NCI) from 1999 to 2001.

Overall, Gabriela R. Rossi has a strong background in immunology, cancer research, and clinical trials development.

Gabriela R. Rossi received their Doctor of Philosophy (Ph.D.) degree in immunology from the Universidad Nacional de Córdoba. The specific duration of their studies is not provided, but it can be inferred that they completed their Ph.D. by 1998.